ImageONE Co., Ltd.
2667・Standard Market・Wholesale Trade
Healthcare Solutions Business
The company's core business, centered on medical information systems, amid the promotion of medical DX
| Period | Current | Previous | Change |
|---|---|---|---|
| Segment revenue (H1 FY2026, ending March 2026) | ¥253 million | ¥479 million (H1 FY2025, ending March 2025) | ↓ |
| Segment profit/loss (H1 FY2026, ending March 2026) | -¥56 million | ¥5 million (H1 FY2025, ending March 2025) | ↓ |
| Segment revenue (Full year FY2025, ended March 2025) | ¥658 million | ― | — |
| Segment loss (Full year FY2025, ended March 2025) | -¥63 million | ― | — |
| Year-on-year revenue change rate (H1 FY2026, ending March 2026) | -47.2% | ― | ↓ |
Business Details
Centered on the Medical Systems field, the company sells PACS, electronic medical records, RIS (radiology information systems), and integrated medical information systems, addressing needs for DX (digital transformation), operational efficiency, and enhanced cybersecurity at medical institutions. In March 2026, the company transferred its unprofitable "ONE Viewer" and "ONE Payment" businesses to a third party, implementing structural reforms to concentrate management resources on the existing Medical Systems field and the medical AI field.
Recent Overview
Divested unprofitable businesses to concentrate resources on medical AI and security fields
Effective March 1, 2026, the company transferred its medical management system "ONE Viewer" and payment agency service "ONE Payment" to Medical Trust Solutions Co., Ltd., recording a gain on business transfer of ¥149 million. Revenue for the current interim period was ¥253 million (down 47.2% year on year), with a segment loss of ¥56 million, affected by the rebound from a large electronic medical record order in the same period of the prior year and the failure to secure highly profitable orders. Going forward, the company plans to concentrate resources on the existing Medical Systems field, such as PACS and electronic medical records, and the medical AI field.
Key Products
Growth Drivers
- Expanding demand for medical information systems driven by government and Ministry of Health, Labour and Welfare-led medical DX promotion policies (standardization of electronic medical records, development of medical information sharing infrastructure)
- Stable revenue base from continued maintenance orders for existing systems such as PACS and electronic medical records (which remained steady in this interim period)
- Strengthened proposals for security solutions amid medical institutions' needs for enhanced cybersecurity and BCP compliance
- Expansion of high-value-added products in the medical AI field through deepened integration between the in-house developed PACS "CLEVINO series" and LPixel's "EIRL series"
- Concentrated allocation of funds and human resources secured through the transfer of the "ONE Viewer" and "ONE Payment" businesses to growth areas
Risks
- Structurally low profitability, with operating losses and segment losses persisting since FY2019 (ending September 2019)
- Risk of revenue fluctuation depending on whether large-scale orders are secured (in this interim period, revenue declined sharply by 47.2% due to the rebound effect from a large electronic medical record order in the same period of the prior year)
- Risk that rebuilding the revenue base after divesting unprofitable businesses will take time, along with uncertainty regarding early profitability in the medical AI field
- Multiple lawsuits related to storage battery transactions (total disclosed damages claims exceeding ¥600 million) may affect business results
- Risk of revenue decline due to price competition with competitors
Last updated: December 23, 2025

